The BASIL trials are vascular surgery trials in the lower limb
Birmingham, England
Joined October 2015
- Tweets278
- Following197
- Followers1.1K
- Likes146
Pinned Tweet
BASIL-2 results revealed! Thank you to everyone's hard work and efforts on the BASIL-2 trial.
The BASIL-2 results have been revealed at #CX2023.
A best endovascular treatment first revascularisation strategy was associated with a better amputation-free survival over the vein bypass group for patients with CLTI.
Watch LIVE now: bit.ly/3mZlHEU
2
549
BASIL-2 has been selected by NIHR to be included as an NIHR alert. Read the summary on NIHR Evidence here evidence.nihr.ac.uk/alert/ar…
Lisa Kelly, BASIL Research Nurse at Solihull Research Showcase – celebrating BASIL trials for International Trials Day! #bepartofresearch
#Thankyou to all the amazing and hard working researchers who are working on BASIL-3. We have now completed recruitment and will be excited to keep you updated with the developments.
7 participants to achieve recruitment! Thank you
@a_saratzis
@LeicResearch
@WythenshaweHosp
@HullHospitals
@GSTTnhs
@EndovascularU
@ChetterIan
#CTD2021 This year has highlighted the true power of science and clinical trials #BASIL3 will answer the important #paclitaxel question! 13 patients to complete recruitment!
#BASIL3 is still recruiting! 20 patients to achieve target. Thank you to @a_saratzis @LeicResearch for recruiting the first patients of 2021.
BASIL-3 is still recruiting! 25 patients to achieve target. Thank you very much to all the sites who are working hard on this trial @WythenshaweHosp @GSTTnhs @LeicResearch @HullHospitals @LTHTResearch @SheffieldHosp @DCHFT @SouthmeadHospit
If you are a West Midlands site that has recruited to BASIL2/3, please could you take a few minutes to complete the PRES 2020/21, the link can be found here: forms.gle/dKE29jX4dEJDy9mL7
You will be required to enter the study ID and your site ID which can be found below...
1
Amazing team @WythenshaweHosp for #recruiting 13 pts to #basil 3 since Sep 2019!!! @NIHRresearch @VSGBI @BSIR_News @NIHRevidence
BASIL-3 will answer this - thank you everyone supporting to the trial!:
Paclitaxel mortality signal inconsistent across different geographies vascularnews.com/paclitaxel-…
2
Thank you to the
@WythenshaweHosp for recrutiing the first BASIL-3 patient of 2020. Just 52 to complete recruitment. @NIHRresearch @CRN_WMid @IN_publishing @BSIR_News @SIRspecialists @VascularNews thank you to those who are helping us find the answer!
Katsanos II. New meta-analysis of outcomes for below knee interventions in CLTI. More worrying signals. jvir.org/article/S1051-0443(…
3
Thank you to the @WythenshaweHosp for recrutiing the first BASIL-3 patient of 2020. Just 52 to complete recruitment. @NIHRresearch @CRN_WMid @IN_publishing @BSIR_News @SIRspecialists @VascularNews
Coming and see us and @VSGBI #VSGBI2019! There is a BASIL investigators meeting happening today in Exchange 10. Tea and Coffee for all. BASIL-3 #istheanswer
Thank you to the @BSIR_News for welcoming @basil_trials today. BASIL-3 is supported by the @US_FDA and @MHRAgovuk @MHRAdevices and open to recruitment! 60 pts to go. #thankyou @Clinical__Trial @WythenshaweHosp @ImperialNHS @GSTTnhs
Thank you to the @BSIR_News for welcoming @basil_trials today. BASIL-3 is supported by the @US_FDA and @MHRAgovuk @MHRAdevices and open to recruitment! 60 pts to go. #thankyou @Clinical__Trial @WythenshaweHosp @ImperialNHS @GSTTnhs
#basil3 will answer the question of use of paclitaxel in fem-pop patients. #thankyou to everyone working hard on this trial. #nihr @NIHRresearch @VascularNews
BASIL-3 has just recruited 1st patient since the pause! We are on our way to answering the important question! @WythenshaweHosp @NIHRresearch @VascularNews
#STARS2019 Dr Cleveland supporting the notion that #Paclitaxel angioplasty is not associated with increased mortality
